For the first time, we demonstrate that, without genetic alteration, high levels of EpCAM expression on Hep3B cells possess unique tumor-initiating capability in the liver microenvironment, and thus possibly contribute distinctly to tumorigenesis. The gene discussed is EPCAM; the disease is neoplasm.